The Impact of Phase-Specific Macrophage Depletion on Intestinal Anastomotic Healing.
DTR
IBD
anastomotic healing
inflammation
intestine
macrophages
monocytes
mucosal inflammation
wound healing
Journal
Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052
Informations de publication
Date de publication:
29 03 2023
29 03 2023
Historique:
received:
27
02
2023
revised:
21
03
2023
accepted:
28
03
2023
medline:
14
4
2023
entrez:
13
4
2023
pubmed:
14
4
2023
Statut:
epublish
Résumé
Intestinal anastomotic healing (AH) is critical in colorectal surgery, since disruptive AH leads to anastomotic leakage, a feared postoperative complication. Macrophages are innate immune cells and are instrumental in orchestrating intestinal wound healing, displaying a functional dichotomy as effectors of both tissue injury and repair. The aim of this study was to investigate the phase-specific function and plasticity of macrophages during intestinal AH. Transgenic CD11b diphtheria toxin receptor (CD11b-DTR) mice were used to deplete intestinal macrophages in a temporally controlled manner. Distal colonic end-to-end anastomoses were created in CD11b-DTR, and wild-type mice and macrophages were selectively depleted during either the inflammatory (day 0-3), proliferative (day 4-10), or reparative (day 11-20) phase of intestinal AH, respectively. For each time point, histological and functional analysis as well as gene set enrichment analysis (GSEA) of RNA-sequencing data were performed. Macrophage depletion during the inflammatory phase significantly reduced the associated inflammatory state without compromising microscopic AH. When intestinal macrophages were depleted during the proliferative phase, AH was improved, despite significantly reduced perianastomotic neoangiogenesis. Lastly, macrophages were depleted during the reparative phase and GSEA revealed macrophage-dependent pathways involved in collagen remodeling, cell proliferation, and extracellular matrix composition. However, AH remained comparable at this late timepoint. These results demonstrate that during intestinal AH, macrophages elicit phase-specific effects, and that therapeutic interventions must critically balance their dual and timely defined role.
Identifiants
pubmed: 37048112
pii: cells12071039
doi: 10.3390/cells12071039
pmc: PMC10093464
pii:
doi:
Substances chimiques
Collagen
9007-34-5
RNA
63231-63-0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
J Exp Med. 2007 Nov 26;204(12):3037-47
pubmed: 18025128
J Immunol. 2004 Apr 1;172(7):4410-7
pubmed: 15034056
Nat Immunol. 2005 Dec;6(12):1191-7
pubmed: 16369558
Gut. 2020 Feb;69(2):252-263
pubmed: 31092589
Nat Rev Immunol. 2011 Oct 14;11(11):723-37
pubmed: 21997792
Front Immunol. 2018 Jan 30;9:127
pubmed: 29441073
Am J Pathol. 2009 Dec;175(6):2454-62
pubmed: 19850888
Proc Natl Acad Sci U S A. 2012 Nov 13;109(46):E3186-95
pubmed: 23100531
Gut. 2021 Jul;70(7):1383-1395
pubmed: 33384336
Br J Surg. 2015 Apr;102(5):462-79
pubmed: 25703524
Cell. 2014 Jul 17;158(2):300-313
pubmed: 25036630
Biomolecules. 2022 Nov 08;12(11):
pubmed: 36359009
Immunol Cell Biol. 2019 Mar;97(3):258-267
pubmed: 30746824
Bioinformatics. 2015 Jan 15;31(2):166-9
pubmed: 25260700
Eur Surg Res. 2009;42(4):249-57
pubmed: 19346745
J Surg Res. 2014 Mar;187(1):202-10
pubmed: 24290527
Nat Protoc. 2009;4(8):1184-91
pubmed: 19617889
Nat Rev Immunol. 2010 Jun;10(6):427-39
pubmed: 20498669
Int J Colorectal Dis. 2014 Dec;29(12):1507-16
pubmed: 25255850
Am J Pathol. 2009 Jul;175(1):132-47
pubmed: 19528348
Nat Immunol. 2014 Oct;15(10):929-937
pubmed: 25151491
Expert Rev Mol Med. 2011 Jul 11;13:e23
pubmed: 21740602
Blood. 2014 Apr 24;123(17):e90-9
pubmed: 24671955
JCI Insight. 2021 Mar 30;6(8):
pubmed: 33784253
J Exp Med. 1985 Mar 1;161(3):475-89
pubmed: 3973536
Front Physiol. 2018 May 01;9:419
pubmed: 29765329
Blood. 2013 Oct 10;122(15):2714-22
pubmed: 23974197
Mucosal Immunol. 2013 May;6(3):498-510
pubmed: 22990622
Sci Rep. 2017 Mar 27;7(1):447
pubmed: 28348370
Am J Pathol. 2014 Apr;184(4):1167-1184
pubmed: 24525152
Microsurgery. 2006;26(3):131-6
pubmed: 16518804
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Genome Biol. 2014;15(12):550
pubmed: 25516281
J Crohns Colitis. 2018 Apr 27;12(5):589-599
pubmed: 29304229
Nat Biotechnol. 2019 Aug;37(8):907-915
pubmed: 31375807
Gut. 2009 Sep;58(9):1300-11
pubmed: 19671558
Nat Rev Immunol. 2017 Jul;17(7):451-460
pubmed: 28461703
Vascul Pharmacol. 2015 Aug;71:31-6
pubmed: 25869514
Gut. 2007 Feb;56(2):176-85
pubmed: 16809419
Sci Transl Med. 2015 May 6;7(286):286ra68
pubmed: 25947163
Vasc Endovascular Surg. 2005 Jul-Aug;39(4):293-306
pubmed: 16079938
BMC Gastroenterol. 2015 Dec 21;15:180
pubmed: 26691961
J Immunol. 2010 Apr 1;184(7):3964-77
pubmed: 20176743
Int J Colorectal Dis. 2021 Oct;36(10):2247-2259
pubmed: 34455473
Semin Liver Dis. 2010 Aug;30(3):245-57
pubmed: 20665377
Gigascience. 2021 Feb 16;10(2):
pubmed: 33590861
J Immunol Res. 2018 Feb 18;2018:6827237
pubmed: 29670921
J Invest Dermatol. 2007 Sep;127(9):2259-67
pubmed: 17460730
Chirurg. 2011 Jan;82(1):41-7
pubmed: 21076802
Inflamm Bowel Dis. 2021 Aug 19;27(9):1379-1393
pubmed: 33512505
Science. 2017 Jun 9;356(6342):1072-1076
pubmed: 28495875
Front Immunol. 2019 Jul 17;10:1642
pubmed: 31379841
J Clin Invest. 2005 Jan;115(1):56-65
pubmed: 15630444
Gut. 2017 Dec;66(12):2098-2109
pubmed: 28615302
Immunity. 2017 May 16;46(5):849-862.e7
pubmed: 28514690
PLoS One. 2018 Mar 22;13(3):e0194249
pubmed: 29566031
Immunol Rev. 2014 Jul;260(1):102-17
pubmed: 24942685
Front Immunol. 2021 Dec 22;12:754475
pubmed: 35003066
Surg Today. 2005;35(4):290-4
pubmed: 15815844